Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil 5 mg Once Daily for Erectile Dysfunction
NCT00422734Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial in erectile dysfunction (ED) comparing Placebo with 5 mg tadalafil (2 arms). Primary endpoints: International Index of Erectile Function - Erectile Function Domain at 12 weeks, Sexual Quality of Life at 12 weeks and 2 more. Started Nov 2006; status: completed.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00422734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00422734.